SK BIOPHARMACEUTICALS revenue breakdown overview

SK BIOPHARMACEUTICALS revenue for the last year amounted to 354.90 B KRW, the most of which — 354.89 B KRW — came from its highest performing source at the moment, New Drug Development, the year earlier bringing 246.18 B KRW. The greatest contribution to the revenue figure was made by United States — last year it brought SK BIOPHARMACEUTICALS 508.89 B KRW, and the year before that — 388.21 B KRW.